Literature DB >> 23685711

Intramuscular myxoma of the buttock mimicking low-grade fibromyxoid sarcoma: diagnostic usefulness of MUC4 expression.

Hideki Yamashita1, Koji Endo, Chikako Takeda, Ryota Teshima, Mitsuhiko Osaki, Haruhiko Yoshida.   

Abstract

Intramuscular myxoma (IM) is a benign intramuscular neoplasm composed of fibroblasts and abundant myxoid stroma. Some malignant soft tissue tumors can undergo myxomatous degeneration, which makes it difficult to distinguish them from IM. We describe a case of IM of the buttock region mimicking low-grade fibromyxoid sarcoma. The tumor appeared as a well-defined ovoid mass with a cystic lesion on MRI images, and mild uptake on PET images was seen. This was originally misdiagnosed as low-grade fibromyxoid sarcoma (LGFMS) after core-needle biopsy. The mass was excised en bloc and sent for histology. The surgical specimen showed the features of LGFMS with the same characteristics as those mentioned in the previous biopsy report. After surgery, MUC4 expression, a highly sensitive and specific immunohistochemical marker for LGFMS, and FUS gene rearrangement by FISH was not detected upon re-examination; therefore, a conclusive diagnosis of IM was made. The patient had no local recurrence at the 3-year follow-up. Our case suggests that IM with mild FDG uptake is frequently confused with other low-grade malignant myxoid tumors. In addition, absence of MUC4 expression is the definitive key to distinguish IM from LGFMS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23685711     DOI: 10.1007/s00256-013-1641-4

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  18 in total

1.  Activating Gs(alpha) mutation in intramuscular myxomas with and without fibrous dysplasia of bone.

Authors:  S Okamoto; M Hisaoka; M Ushijima; S Nakahara; S Toyoshima; H Hashimoto
Journal:  Virchows Arch       Date:  2000-08       Impact factor: 4.064

2.  The appearance of Mazabraud's syndrome on 18F-FDG PET/CT.

Authors:  Amit Singnurkar; J P Phancao; Deep S Chatha; Jerry Stern
Journal:  Skeletal Radiol       Date:  2007-06-23       Impact factor: 2.199

3.  Intramuscular myxoma: characteristic MR imaging features.

Authors:  Laura W Bancroft; Mark J Kransdorf; David M Menke; Mary I O'Connor; William C Foster
Journal:  AJR Am J Roentgenol       Date:  2002-05       Impact factor: 3.959

4.  Giant paravertebral myxoma.

Authors:  A Rashid; H B Abdul-Jabar; S Karmani; K Rezajooi; A T H Casey
Journal:  Eur Spine J       Date:  2010-05-21       Impact factor: 3.134

5.  Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene.

Authors:  Fredrik Mertens; Christopher D M Fletcher; Cristina R Antonescu; Jean-Michel Coindre; Maurizio Colecchia; Henryk A Domanski; Erinn Downs-Kelly; Cyril Fisher; John R Goldblum; Louis Guillou; Robin Reid; Juan Rosai; Raf Sciot; Nils Mandahl; Ioannis Panagopoulos
Journal:  Lab Invest       Date:  2005-03       Impact factor: 5.662

6.  GNAS1 mutations occur more commonly than previously thought in intramuscular myxoma.

Authors:  David Delaney; Tim C Diss; Nadege Presneau; Sandra Hing; Fitim Berisha; Bernadine D Idowu; P O'Donnell; John A Skinner; Roberto Tirabosco; Adrienne M Flanagan
Journal:  Mod Pathol       Date:  2009-03-13       Impact factor: 7.842

7.  Imaging of soft-tissue myxoma with emphasis on CT and MR and comparison of radiologic and pathologic findings.

Authors:  Mark D Murphey; Gina A McRae; Julie C Fanburg-Smith; H Thomas Temple; Alan M Levine; Albert J Aboulafia
Journal:  Radiology       Date:  2002-10       Impact factor: 11.105

8.  Intramuscular myxoma--a clinicopathological study of twenty-three cases.

Authors:  M Miettinen; K Höckerstedt; J Reitamo; S Tötterman
Journal:  Am J Clin Pathol       Date:  1985-09       Impact factor: 2.493

9.  FDG PET/CT and MR imaging of intramuscular myxoma in the gluteus maximus.

Authors:  Jun Nishio; Masatoshi Naito
Journal:  World J Surg Oncol       Date:  2012-06-30       Impact factor: 2.754

10.  Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix.

Authors:  Stefan M Willems; Alex B Mohseny; Crina Balog; Raj Sewrajsing; Inge H Briaire-de Bruijn; Jeroen Knijnenburg; Anne-Marie Cleton-Jansen; Raf Sciot; Christopher D M Fletcher; André M Deelder; Karoly Szuhai; Paul J Hensbergen; Pancras C W Hogendoorn
Journal:  J Cell Mol Med       Date:  2009-03-13       Impact factor: 5.310

View more
  3 in total

1.  18F-FDG PET/CT and MRI features of myxoid liposarcomas and intramuscular myxomas.

Authors:  Brendan W Lunn; Laurel A Littrell; Doris E Wenger; Stephen M Broski
Journal:  Skeletal Radiol       Date:  2018-06-20       Impact factor: 2.199

2.  A Low-Grade Fibromyxoid Sarcoma of the Internal Abdominal Oblique Muscle.

Authors:  Masakazu Hashimoto; Kei Koide; Michinori Arita; Koji Kawaguchi; Yoshihiro Mikuriya; Jun Iwata; Toshiyuki Iwamoto
Journal:  Case Rep Surg       Date:  2016-05-10

3.  Radiomic features from MRI distinguish myxomas from myxofibrosarcomas.

Authors:  Teresa Martin-Carreras; Hongming Li; Kumarasen Cooper; Yong Fan; Ronnie Sebro
Journal:  BMC Med Imaging       Date:  2019-08-15       Impact factor: 1.930

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.